Put companies on watchlist
HBM Healthcare Investments AG
ISIN: CH0012627250
WKN: 984345
About
Company Snapshot
New: Enable Investor Alerts
Be informed about new publications
New: AI Factsheet

Corporate News meets AI! 
Content analysis and summary

EN GIF 300X250

HBM Healthcare Investments AG · ISIN: CH0012627250 · EQS - Company News (191 News)
Country: Switzerland · Primary market: Switzerland · EQS NID: 1275476
01 February 2022 05:46PM

Key Figures 31.01.2022


HBM Healthcare Investments AG / Key word(s): Monthly Figures
Key Figures 31.01.2022

01.02.2022 / 17:46


 

in CHF

Performance in %

 

31.01.2022

MTD

FYTD

CYTD

NAV

310.67

-7.6

4.5

-7.6

Share Price

295.50

-12.8

-7.4

-12.8

Total Net Assets (in million)

2'161

 

 

 

HBM Healthcare Investments AG
Bundesplatz 1
CH-6300 Zug - Switzerland
Tel.  +41 41 710 75 77
Fax  +41 41 710 75 78
 
Wenn Sie keine Mitteilungen von HBM Healthcare Investments mehr wünschen, können Sie diese hier abbestellen
Should you wish to unsubscribe from all HBM Healthcare Investments news, please unsubscribe here.
 
Disclaimer:

This message may contain confidential or privileged Information and is intended only for the use of the addressee named above. If you are not the intended recipient of this message, you are hereby notified that you must not use, copy, disclose or take any action based on this message or information herein. If you have received this message by error, please advise the sender immediately and delete this message. The publication is for information purposes only and does not constitute an offer to sell or a solicitation to buy or subscribe for securities. Past performance is not a reliable indicator or guarantee of future results, prices of shares and the income from them may fall as well as rise and investors may not get back the amount originally invested. The investor must be aware of the investment risk and personal risk ability. Some information quoted was obtained from external sources HBM considers to be reliable. HBM cannot guarantee the adequacy, accuracy, timeliness or completeness of or be held responsible or liable for errors of fact regarding such data and information obtained from third parties, and this data may change with market conditions.

If the email looks unformatted, please use this alternative link.


End of Media Release


Language: English
Company: HBM Healthcare Investments AG
Bundesplatz 1
6300 Zug
Switzerland
Phone: +41438887171
Fax: +41438887172
E-mail: info@hbmhealthcare.com
Internet: https://www.hbmhealthcare.com
ISIN: CH0012627250
Valor: 1262725
Listed: SIX Swiss Exchange
EQS News ID: 1275476

 
End of News EQS News Service

1275476  01.02.2022 

fncls.ssp?fn=show_t_gif&application_id=1275476&application_name=news&site_id=boersengefluester_html
Visual performance / price development - HBM Healthcare Investments AG
Smart analysis and research tools can be found here.

This publication was provided by our content partner EQS3.

EQS Newswire
via EQS - Newsfeed
EQS Group AG ©2024
(DGAP)
Contact:
Karlstraße 47 D-80333 München
+49 (0) 89 444 430-000

 

SMART * AD
EN GIF 970X250

P R O D U C T   S U G G E S T I O N S

The information presented here has been provided by our content partner EQS-Group. The originator of the news is the respective issuer, the company relating to the news, a publication service provider (press or information agency) which uses the distribution service of EQS to transmit company news to shareholders, investors, investors or interested parties. The original publications and other company-relevant information can be found at eqs-news.com.


The information you can access does not constitute investment advice. The presentation of our cooperation partners, where the implementation of investment decisions would be possible depending on the individual risk profile, is solely at the discretion of the person using the service. We only present companies of which we are convinced that the range of services and customer service will satisfy discerning investors.

If you are considering leverage products, familiarise yourself with the typical characteristics of the financial instruments beforehand. Take the time to determine the risk content of the planned investment before making an investment decision. Bear in mind that a total loss cannot be ruled out with leverage products.

For newcomers to the subject, we offer various options in both the training and the tools section, through which you can train theoretical knowledge and practical experience and thus improve your skills. The offer ranges from participation in webinars to personal mentoring. The range is continuously being expanded.


1 Lab features are usually functionalities that emerge from the think tank of the investor community. In the early stages, these are experimental functionalities whose development process is largely determined by use and the resulting feedback from the community. When integrating external services or functionalities, the functionality can only be guaranteed to the extent that the individual process elements, such as interfaces, interact with each other.